Expanding the Scope of the National Practice Oncology Benchmark Would Be a Critical Source for Understanding Outpatient Oncology Practice Costs and Profits in a Time of Change

扩大国家肿瘤诊疗基准的范围，对于了解变革时期门诊肿瘤诊疗的成本和利润至关重要。